MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug

Journal of Orthopaedic Research

Volumn 32, Issue 8, 2014, Pages 1075-1082

  Osaka, Eiji ^a,b   Yang, Xiaoqian ^a   Shen, Jacson K ^a   Yang, Pei ^a   Feng, Yong ^a   Mankin, Henry J ^a   Hornicek, Francis J ^a   Duan, Zhenfeng ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chordoma; invasion; migration; miRNA 1 (miR 1); slug

Indexed keywords

MATRIGEL; MICRORNA 1; TRANSCRIPTION FACTOR SLUG;

ARTICLE; CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHORDOMA; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; WOUND HEALING;

CHORDOMA; INVASION; MIGRATION; MIRNA-1 (MIR-1); SLUG;

AGED; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHORDOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; TRANSCRIPTION FACTORS;

EID: 84903398129     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22632     Document Type: Article

References (31)

1. Sciubba DM, Chi JH, Rhines LD, et al. 2008. Chordoma of the spinal column. Neurosurg Clin N Am 19: 5-15.
2. Chambers PW, Schwinn CP., 1979. Chordoma. A clinicopathologic study of metastasis. Am J Clin Pathol 72: 765-776.
3. Fuchs B, Dickey ID, Yaszemski MJ, et al. 2005. Operative management of sacral chordoma. J Bone Joint Surg Am 87: 2211-2216.
4. Osaka S, Kodoh O, Sugita H, et al. 2006. Clinical significance of a wide excision policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol 132: 213-218.
5. Stacchiotti S, Casali PG, Lo Vullo S, et al. 2010. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 17: 211-219.
6. Farazi TA, Spitzer JI, Morozov P, et al. 2011. miRNAs in human cancer. J Pathol 223: 102-115.
7. Duan Z, Choy E, Nielsen GP, et al. 2010. Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res 28: 746-752.
8. Nelson KM, Weiss GJ., 2008. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther 7: 3655-3660.
9. Tominaga E, Yuasa K, Shimazaki S, et al. 2013. MicroRNA-1 targets Slug and endows lung cancer A549 cells with epithelial and anti-tumorigenic properties. Exp Cell Res 319: 77-88.
10. Fleming JL, Gable DL, Samadzadeh-Tarighat S, et al. 2013. Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice. PeerJ 1: e68.
11. Shih JY, Yang PC., 2011. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 32: 1299-1304.
12. Riemenschnitter C, Teleki I, Tischler V, et al. 2013. Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy. Springerplus 2: 695.
13. Hasan MR, Sharma R, Saraya A, et al. 2013. Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients. PLoS ONE 8: e82846.
14. Yu Q, Zhang K, Wang X, et al. 2010. Expression of transcription factors snail, slug, and twist in human bladder carcinoma. J Exp Clin Cancer Res 29: 119.
15. Uchikado Y, Okumura H, Ishigami S, et al. 2011. Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer 14: 41-49.
16. Scheil S, Bruderlein S, Liehr T, et al. 2001. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32: 203-211.
17. Bruderlein S, Sommer JB, Meltzer PS, et al. 2010. Molecular characterization of putative chordoma cell lines. Sarcoma 2010: 630129.
18. Liu X, Nielsen GP, Rosenberg AE, et al. 2012. Establishment and characterization of a novel chordoma cell line: CH22. J Orthop Res 30: 1666-1673.
19. Duan Z, Bradner JE, Greenberg E, et al. 2006. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation. Clin Cancer Res 12: 6844-6852.
20. Kawakami K, Enokida H, Chiyomaru T, et al. 2012. The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer 48: 827-836.
21. Leone V, D'Angelo D, Rubio I, et al. 2011. MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha. J Clin Endocrinol Metab 96: E1388-E1398.
22. Li D, Yang P, Li H, et al. 2012. MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. Life Sci 91: 440-447.
23. Liu YN, Yin JJ, Abou-Kheir W, et al. 2013. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene 32: 296-306.
24. Nasser MW, Datta J, Nuovo G, et al. 2008. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 283: 33394-33405.
25. Nohata N, Sone Y, Hanazawa T, et al. 2011. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2: 29-42.
26. Wang F, Song G, Liu M, et al. 2011. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett 585: 3263-3269.
27. Yamasaki T, Yoshino H, Enokida H, et al. 2012. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. Int J Oncol 40: 1821-1830.
28. Yoshino H, Enokida H, Chiyomaru T, et al. 2012. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochem Biophys Res Commun 417: 588-593.
29. Karamchandani J, Wu MY, Das S, et al. 2013. Highly proliferative sellar chordoma with unusually rapid recurrence. Neuropathology 33: 424-430.
30. Bayrak OF, Gulluoglu S, Aydemir E, et al. 2013. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. J Neurooncol 115: 143-151.
31. Hirai H, Verma M, Watanabe S, et al. 2010. MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. J Cell Biol 191: 347-365.